CHICAGO—AirAnswers has announced a new partnership with Superstratum. Both companies have joined forces to identify and alleviate indoor mycotoxins and molds that can contribute to symptoms associated with sick building syndrome. Sick building syndrome and other health issues could potentially be caused by molds, mycotoxins, allergens, and viruses in indoor spaces. AirAnswers is the only commercially available air sampling system that detects, identifies, and measures all biological particles including molds, mycotoxins, viruses, and allergens, down to 0.1 microns in size. AirAnswers’ technology provides users with the capability to assess and to monitor indoor spaces for the presence of biological contaminants. By identifying the indoor airborne contaminants with AirAnswers, Superstratum provides unique, patented, protocols and products to remove mycotoxins and molds from their indoor spaces.
“Mycotoxins and other unseen pathogens have been affecting health and often being written off as “phantom illness”. Superstratum products are designed to address the causes of sick building syndrome, providing long term protection, so that you can live in healthy environments,” said Seth Jones, CEO of Superstratum.
“Our partnership with Superstratum is a major step forward in our Air Quality Program that emphasizes Assessment-Remediation-Monitoring as the way to ensure healthier environments,” said Jim Koziarz, CEO of AirAnswers. “Partnerships like this are game changers in the indoor air quality market and I’m looking forward to a very successful collaboration with Superstratum.”
